Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-10

Clinical Trial Update: Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This study updates results from a Phase 2 trial evaluating vandetanib in combination with chemotherapy for advanced non-small cell lung cancer. The results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caprelsa (vandetanib)

Snippet

Sponsor: PrECOG, LLC. | Conditions: Lung Cancer, Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-07-10